Related Experiment Video
Updated: May 13, 2026
07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
Intradetrusor onabotulinumtoxinA injection: how I do it
Patrick J Shenot1, J Ryan Mark
1Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.
The Canadian Journal of Urology
|February 26, 2013
Summary
OnabotulinumtoxinA offers a new treatment for overactive bladder and urinary incontinence. This injectable therapy targets refractory detrusor overactivity by blocking acetylcholine release, improving patient quality of life.
Area of Science:
- Urology
- Pharmacology
- Neuroscience
Background:
- Overactive bladder (OAB) is common and impacts quality of life.
- Neurogenic or idiopathic causes exist for OAB.
- Antimuscarinics are traditional OAB treatments.
Purpose of the Study:
- To describe the technique for OnabotulinumtoxinA therapy for refractory detrusor overactivity.
- To outline essential equipment for the procedure.
- To provide guidance on avoiding common technical pitfalls.
Main Methods:
- Utilizing OnabotulinumtoxinA injection therapy.
- Focus on the procedural technique.
- Identification of necessary equipment and troubleshooting.
Main Results:
- OnabotulinumtoxinA is an effective option for refractory detrusor overactivity.
- The manuscript details the administration technique.
- Key equipment and tips for successful treatment are provided.
Conclusions:
- OnabotulinumtoxinA is a valuable addition to OAB management.
- Proper technique and equipment are crucial for efficacy.
- This therapy addresses challenging cases of urinary incontinence due to detrusor overactivity.
More Related Videos
Related Concept Videos
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...